Idenix Pharmaceuticals Shares Jumped: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Idenix Pharmaceuticals (Nasdaq: IDIX  ) got a positive diagnosis today and climbed 43% after the company released positive data for its hepatitis C drug.

So what: The company said that in a phase 2b trial of IDX184, the drug achieved rapid virologic response in 73% of patients using 100 mg and 63% of patients using 50 mg. The stock also got some of its boost after Bristol-Myers Squibb (NYSE: BMY  ) bought Inhibitex (Nasdaq: INHX  ) for $2.5 billion, a 163% premium from its Friday close.

Now what: Makers of hepatitis C drugs are hot today, and analysts think this could lead to more activity in the sector. Baird and Bernstein analysts were among those who think this could pump up these stocks as companies compete to find treatments for the virus. If you own shares, I would take some profit today just to reduce risk, but these stocks appear to be at the beginning of a run-up right now.

Interested in more info on Idenix Pharmaceuticals? Add it to your watchlist by clicking here.

Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 1754797, ~/Articles/ArticleHandler.aspx, 4/20/2014 5:51:57 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement